Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 2 | -$0.12 | -$0.04 | -$0.08 |
Q2 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
Q3 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
Q4 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
Q1 2026 | 1 | -$0.04 | -$0.04 | -$0.04 |
Q2 2026 | 1 | -$0.04 | -$0.04 | -$0.04 |
Q3 2026 | 1 | -$0.03 | -$0.03 | -$0.03 |
Q4 2026 | 1 | -$0.03 | -$0.03 | -$0.03 |
OPKO Health, Inc. last posted its earnings results on Thursday, February 27th, 2025. The company reported $0.01 earnings per share for the quarter, topping analysts' consensus estimates of $-0.08 by $0.09. The company had revenue of 183.64 M for the quarter and had revenue of 713.14 M for the year. OPKO Health, Inc. has generated $0 earnings per share over the last year ($-0.0767 diluted earnings per share) and currently has a price-to-earnings ratio of -18.39. OPKO Health, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 30th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
03/21/2025 | Q4 2024 | N/A | $0.02 | N/A | $155.42 M | $183.64 M |
11/07/2024 | Q3 2024 | -$0.10 | $0.04 | 0.14 | $181.52 M | $173.63 M |
08/07/2024 | Q2 2024 | -$0.09 | -$0.01 | 0.08 | $184.70 M | $182.19 M |
05/07/2024 | Q1 2024 | -$0.09 | -$0.12 | -0.03 | $182.99 M | $173.69 M |
03/01/2024 | Q4 2023 | N/A | -$0.09 | N/A | $177.53 M | $181.90 M |
11/06/2023 | Q3 2023 | -$0.09 | -$0.11 | -0.02 | $174.78 M | $178.60 M |
08/03/2023 | Q2 2023 | -$0.07 | -$0.03 | 0.04 | $201.97 M | $265.42 M |
05/03/2023 | Q1 2023 | -$0.07 | -$0.02 | 0.05 | $193.35 M | $237.60 M |
02/27/2023 | Q4 2022 | N/A | -$0.11 | N/A | $168.21 M | $185.40 M |
11/08/2022 | Q3 2022 | -$0.10 | -$0.11 | -0.01 | $183.51 M | $179.74 M |
08/04/2022 | Q2 2022 | -$0.00 | -$0.14 | -0.14 | $326.87 M | $309.89 M |
05/09/2022 | Q1 2022 | -$0.08 | -$0.08 | -0 | $332.62 M | $329.22 M |
03/01/2022 | Q4 2021 | N/A | -$0.11 | N/A | $329.83 M | $401.30 M |
10/28/2021 | Q3 2021 | $0.02 | $0.04 | 0.02 | $302.27 M | $385.81 M |
07/29/2021 | Q2 2021 | -$0.01 | -$0.03 | -0.01 | $456.36 M | $442.41 M |
04/28/2021 | Q1 2021 | $0.05 | $0.05 | 0 | $494.16 M | $545.17 M |
02/18/2021 | Q4 2020 | $0.04 | $0.05 | 0.01 | $443.10 M | $494.60 M |
10/29/2020 | Q3 2020 | $0.04 | $0.04 | -0 | $378.66 M | $428.06 M |
07/31/2020 | Q2 2020 | N/A | $0.05 | N/A | $245.60 M | $301.21 M |
05/06/2020 | Q1 2020 | -$0.09 | -$0.09 | -0 | $218.00 M | $211.47 M |
OPKO Health, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 30th, 2025 based offlast year's report dates.
In the previous quarter, OPKO Health, Inc. (:OPK) reported $0.01 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.08 by $0.09.
The conference call for OPKO Health, Inc.'s latest earnings report can be listened to online.
The conference call transcript for OPKO Health, Inc.'s latest earnings report can be read online.
OPKO Health, Inc. (:OPK) has a recorded annual revenue of $713.14 M.
OPKO Health, Inc. (:OPK) has a recorded net income of $-53,224,000.OPKO Health, Inc. has generated $-0.0767 earnings per share over the last four quarters.
OPKO Health, Inc. (:OPK) has a price-to-earnings ratio of -18.39 and price/earnings-to-growth ratio is -0.31.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED